Neratinib May Be Efficacious for Treatment of HER2-Positive Breast Cancer
Neratinib demonstrated clinical efficacy for patients with HER2-positive, hormone-receptor-negative breast cancer, in a phase 2 study.
All articles by John Eckman
Stem-cell Transplantation May Improve Overall Survival of Patients With Relapsed MM
Salvage autologous stem-cell transplantation (ASCT) may improve overall survival (OS) of patients with relapsed multiple myeloma treated with an initial ASCT.
Sociodemographic Factors May Affect Early Treatment of Pancreatic Cancer
Sociodemographic factors, such as residential instability, low income, and living in a rural area, negatively affect the odds of a patient with pancreatic cancer undergoing surgical resection, even in a single-payer universal health care system.
NCI Launches $12m Study on Breast Cancer Genetics
The National Cancer Institute (NCI) has provided a 12 million dollar grant to fund a collaborative study on breast cancer genetics in African American women.
Circulating Tumor DNA May Accurately Predict Recurrence of Colon Cancer
A well-timed, sensitive liquid biopsy could effectively predict post-surgical recurrence of stage 2 colon cancer.
Bendamustine, Gemcitabine, Vinorelbine Promising Treatment for Relapsed or Refractory Hodgkin Lymphoma
BeGEV appears to provide clinical benefit for patients with relapsed or refractory Hodgkin lymphoma, and ought to be developed further.
Xilonix Promising for Patients With Advanced or Refractory Colorectal Cancer
This novel therapy is promising for patients with advanced colorectal cancer, and an examination of a patient’s “health status,” understood as observable symptoms relating to disease, ought to be considered a measure of treatment efficacy for patients in this disease group.
Rituximab Maintenance Therapy Promising for Patients With Pre-treated CLL
Maintenance therapy with the monoclonal antibody, rituximab, may improve progression-free survival for patients with chronic lymphocytic leukemia (CLL).
Genomic Data Commons More Than Doubles Number of Genomic Profiles With New Sharing Agreement
A new data sharing agreement promises major advances in the developing area of personalized medicine.
Droplet Digital PCR Promising for Detecting Recurrent Ewing Sarcoma
A droplet digital polymerase chain reaction (PCR) technique shows promise for predicting recurrence of Ewing sarcoma in specific patients.
- Loading...
Loading...
Next post in Sarcoma
Loading... 
Loading...